Search results :

Candesartan

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C09CA06

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4
Kidney function abnormal 6.3% x x x
Hypotension 4.1% x x x
Headache 0.6% x x x x
Dizziness 0.3% x x x x
Agranulocytosis postmarketing x x x x
Anaemia postmarketing x x
Angioedema postmarketing x x x x
Cough postmarketing x x x x
Rash postmarketing x x x x
Cardiac failure postmarketing x x
Cardiac failure congestive postmarketing x x
Hepatitis postmarketing x x x x
Hepatitis A postmarketing x x
Hyperkalaemia postmarketing, 2.4% x x x x
Hypertension postmarketing x x
Hyponatraemia postmarketing x x x x
Leukopenia postmarketing x x x x
Neutropenia postmarketing x x x x
Pruritus postmarketing x x x x
Renal failure postmarketing x x
Rhabdomyolysis postmarketing x x x x
Thrombocytopenia postmarketing x x
Urticaria postmarketing x x x x
Blood urea increased postmarketing x x
Malnutrition postmarketing x x x x
Transaminases increased postmarketing x x
Serum creatinine increased postmarketing x x
Hyperuricaemia postmarketing x x
Bilirubin total increased postmarketing x x
Renal impairment postmarketing x x
Abdominal pain x x
Albuminuria x x
Angina pectoris x x
Anxiety x x
Arthralgia x x
Asthenia x x
Back pain x x x x
Mental disorder x x
Coagulopathy x x
Bronchitis x x
Chest pain x x
Diarrhoea x x
Dyspepsia x x
Dyspnoea x x
Epistaxis x x
Fatigue x x
Body temperature increased x x
Gastroenteritis x x
Gastrointestinal disorder x x
Haematuria x x
Haemorrhage x x
Hyperglycaemia x x
Hypertriglyceridaemia x x
Nephropathy x x x x
Myocardial infarction x x
Nausea x x
Palpitations x x
Paraesthesia x x
Pharyngitis x x x x
Rhinitis x x x x
Sinusitis x x
Tachycardia x x
Upper respiratory tract infection x x x x
Urinary tract disorder x x
Vertigo x x
Vomiting x x
Oedema peripheral x x
Creatine phosphokinase increased x x
Myalgia x x
Sweating increased x x
Somnolence x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CANDESARTAN

Side effects:22
Source:FDA Structured Product Label

CANDESARTAN

Side effects:22
Source:FDA Structured Product Label

CANDESARTAN

Side effects:69
Source:FDA Structured Product Label

CANDESARTAN

Side effects:71
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label